Tracking Real-World results for advanced prostate cancer treatment
NCT ID NCT07406282
Summary
This study aims to understand how doctors use the drug darolutamide in real-world clinics to treat men with metastatic prostate cancer that has spread at diagnosis. Researchers will look back at the medical records of about 1,400 men to see who gets the drug, how they take it, and what their outcomes are. The goal is to gather practical knowledge to help guide future treatment decisions, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Precision Point Specialty LLC PPS Analytics, a Specialty Networks LLC Company
RECRUITINGCleveland, Ohio, 44114-2619, United States
Conditions
Explore the condition pages connected to this study.